GlassScriptPhysician profile
Michael W Johnson
NPI 1972583391
$2,542.47
in general payments reported to CMS, 2019-2025
10 companies · $596 in 2025
The $596 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $179 · 2021: $193 · 2022: $209 · 2023: $599 · 2024: $331 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,526.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $515.34 | 2019-2024 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $485.66 | 2022-2025 | Infuse, Infuse Multifocal |
| Alcon Vision LLC | $460.98 | 2019-2025 | Precision7, Clareon |
| Johnson & Johnson Vision Care, INC. | $427.91 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $203.86 | 2019-2021 | |
| Rxsight INC | $176.43 | 2024-2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| New World Medical,INC. | $115.86 | 2023 | |
| Glaukos Corporation | $95.67 | 2025 | Idosetr |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Abbvie INC. | $21.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.